Evidence map›Paper›PMID 16436639›Full record

ArticleThe Journal of molecular diagnostics : JMD2006

Multiplexed detection of anthrax-related toxin genes.

Michael J Moser, Deanna R Christensen, David Norwood, James R Prudent

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Optimization of an unnatural base pair toward natural-like replication.Journal of the American Chemical Society · 2009
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael J MoserEragen Biosciences, Inc., 918 Deming Way, Madison, WI 53717-1944, USA.
Deanna R Christensen
David Norwood
James R Prudent
United States Army Medical Research Institute of Infectious Diseases · US

Funding

Rapid Turn-arround Multiplex Testing: Bioweapon AgentsR44AI052898 · NIAID · ERAGEN BIOSCIENCES, INC. · PI PRUDENT, JAMES R. · 2003 to 2004
$939k
Rapid Turn-around Testing for Bioterrorism AgentsR43AI052898 · NIAID · ERAGEN BIOSCIENCES, INC. · PI PRUDENT, JAMES R. · 2002 to 2002
$105k
NIAID NIH HHS AI052898NIAID NIH HHS R43 AI052898NIAID NIH HHS R44 AI052898
6 · The paper itself

Abstract

Simultaneous analysis of three targets in three colors on any real-time polymerase chain reaction (PCR) instrument would increase the flexibility of real-time PCR. For the detection of Bacillus strains that can cause inhalation anthrax-related illness, this ability would be valuable because two plasmids confer virulence, and internal positive controls are needed to monitor the testing in cases lacking target-specific signals. Using a real-time PCR platform called MultiCode-RTx, multiple assays were developed that specifically monitor the presence of Bacillus anthracis-specific virulence plasmid-associated genes. In particular for use on LightCycler-1, two triplex RTx systems demonstrated high sensitivity with limits of detection nearing single-copy levels for both plasmids. Specificity was established using a combination of Ct values and correct amplicon melting temperatures. All reactions were further verified by detection of an internal positive control. For these two triplex RTx assays, the analytical detection limit was one to nine plasmid copy equivalents, 100% analytical specificity with a 95% confidence interval (CI) of 9%, and 100% analytical sensitivity with a CI of 2%. Although further testing using clinical or environmental samples will be required to assess diagnostic sensitivity and specificity, the RTx platform achieves similar results to those of probe-based real-time systems.

Indexed as

Sequence Analysis, DNAAntigens, BacterialBacillus anthracisBacterial ToxinsBacterial Typing TechniquesFluorescent DyesGene DosagePolymerase Chain ReactionReproducibility of ResultsSensitivity and Specificityanthrax toxinAntigens, BacterialBacterial ToxinsFluorescent Dyes

Identifiers

PMID16436639
PMCPMC1592686
OpenAlexW2038721876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.